0
0

STOP GAMES Act of 2023

1/5/2024, 8:15 PM

Summary of Bill HR 3030

The STOP GAMES Act of 2023, also known as Bill 118 hr 3030, is a piece of legislation introduced in the US Congress aimed at addressing concerns related to the manipulation of online gaming platforms for financial gain. The bill seeks to crack down on individuals and organizations that engage in fraudulent activities such as cheating, hacking, and exploiting vulnerabilities in online games in order to profit illegally.

The STOP GAMES Act includes provisions that would make it illegal to use software or devices to cheat in online games, as well as to sell or distribute cheat codes or hacks. The bill also seeks to hold online gaming platforms accountable for taking action against cheaters and ensuring fair play for all users.

Additionally, the STOP GAMES Act includes measures to enhance cybersecurity protections for online gaming platforms, in order to prevent data breaches and protect the personal information of users. The bill also calls for increased cooperation between law enforcement agencies and online gaming companies to investigate and prosecute individuals involved in fraudulent activities. Overall, the STOP GAMES Act of 2023 aims to safeguard the integrity of online gaming platforms and protect consumers from fraudulent practices. It represents a bipartisan effort to address a growing issue in the gaming industry and ensure a fair and secure online gaming experience for all users.

Congressional Summary of HR 3030

Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon Act of 2023 or the STOP GAMES Act of 2023

This bill specifies factors that the Food and Drug Administration (FDA) must use in determining if a petition is submitted with the primary purpose of delaying the approval of a pending new or generic drug application. (Current law allows third parties, including interested parties, to file petitions asking the FDA to take various actions, such as to consider certain issues pertaining to an application for market approval for a drug; current law also allows the FDA to deny a petition that is submitted with the primary purpose of delaying approval of an application.)

The factors include (1) whether the petitioner filed serial petitions raising issues that could have been known to the petitioner when an earlier petition was filed, and (2) whether the petition has any data or information to support its scientific positions.

If the FDA finds that delay is the primary purpose of the petition, it must refer the matter to the Federal Trade Commission.

A party filing a petition must do so within 60 days of when the party first learned of the information on which the petition is based.

Current Status of Bill HR 3030

Bill HR 3030 is currently in the status of Bill Introduced since April 28, 2023. Bill HR 3030 was introduced during Congress 118 and was introduced to the House on April 28, 2023.  Bill HR 3030's most recent activity was Referred to the Subcommittee on Health. as of May 5, 2023

Bipartisan Support of Bill HR 3030

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
2
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 3030

Primary Policy Focus

Health

Potential Impact Areas

- Administrative remedies
- Congressional oversight
- Food and Drug Administration (FDA)
- Government information and archives
- Prescription drugs

Alternate Title(s) of Bill HR 3030

STOP GAMES Act of 2023
STOP GAMES Act of 2023
Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon Act of 2023
To amend subsection (q) of section 505 of the Federal Food, Drug, and Cosmetic Act to clarify the process for denying certain petitions whose primary purpose is to delay the approval of an application submitted under subsection (b)(2) or (j) of such section 505, and for other purposes.

Comments